Cresco Labs Inc. (CRLBF) closed the most recent trading day at $2.29, moving -0.43% from the previous trading session. The stock’s performance was behind the S&P 500’s daily gain of 0.15%. Elsewhere, the Dow saw a downswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.32%.
Shares of the company witnessed a gain of 51.32% over the previous month, beating the performance of the Medical sector with its loss of 4.03% and the S&P 500’s gain of 1.65%.
Analysts and investors alike will be keeping a close eye on the performance of Cresco Labs Inc. in its upcoming earnings disclosure. The company is expected to report EPS of -$0.02, up 77.78% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $183.43 million, down 5.54% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.06 per share and revenue of $742.34 million, which would represent changes of +64.71% and -3.7%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Cresco Labs Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the
